What is Abhayrab rabies vaccine used for?

Abhayrab rabies vaccine is indicated for Pre-exposure prophylaxis against rabies.

Who makes Abhayrab rabies vaccine?

Abhayrab rabies vaccine is developed by PATH.

What development phase is Abhayrab rabies vaccine in?

Abhayrab rabies vaccine is in Phase 2.

What are the side effects of Abhayrab rabies vaccine?

Common side effects include Pain, redness, or swelling at the injection site.

Last reviewed 2026-04-23 · How we verify

Abhayrab rabies vaccine

PATH · Phase 2 active Biologic

Abhayrab rabies vaccine works by stimulating the body's immune system to produce antibodies against rabies.

Abhayrab rabies vaccine works by stimulating the body's immune system to produce antibodies against rabies. Used for Pre-exposure prophylaxis against rabies.

At a glance

Generic name	Abhayrab rabies vaccine
Sponsor	PATH
Modality	Biologic
Therapeutic area	Immunology
Phase	Phase 2

Mechanism of action

The vaccine contains inactivated rabies virus particles that are unable to cause disease but can still trigger an immune response. This immune response helps the body to recognize and fight off rabies virus in the future.

Approved indications

Pre-exposure prophylaxis against rabies

Common side effects

Pain, redness, or swelling at the injection site

Key clinical trials

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Abhayrab rabies vaccine CI brief — competitive landscape report
Abhayrab rabies vaccine updates RSS · CI watch RSS
PATH portfolio CI